STOCK TITAN

Calumet (CLMT) director receives 3,461 Restricted Stock Units as equity award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

SANDERS BRADFORD TIMOTHY reported acquisition or exercise transactions in this Form 4 filing.

Calumet, Inc. director Bradford Timothy Sanders received a grant of 3,461 Restricted Stock Units (RSUs) that are the economic equivalent of 3,461 shares of common stock. The RSUs vest on the earlier of June 2, 2027 or the company’s 2027 Annual Meeting and will be settled in shares upon vesting.

Positive

  • None.

Negative

  • None.
Insider SANDERS BRADFORD TIMOTHY
Role null
Type Security Shares Price Value
Grant/Award Restricted Stock Unit 3,461 $0.00 --
Holdings After Transaction: Restricted Stock Unit — 3,461 shares (Direct, null)
Footnotes (1)
  1. Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share. Restricted Stock Units vest upon the earlier of June 2, 2027 or the date on which Calumet, Inc. holds its Annual Meeting in 2027. Restricted Stock Units will be settled upon vesting.
RSUs granted 3,461 units Restricted Stock Units awarded to director on June 2, 2026
Equivalent shares 3,461 shares Each RSU equals one share of common stock
Grant price $0.00 per unit Equity award, no cash paid by director
Post-award RSUs 3,461 units Total derivative holdings following the transaction
Vesting date trigger June 2, 2027 Vests earlier of June 2, 2027 or 2027 Annual Meeting
Restricted Stock Unit financial
"Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
economic equivalent financial
"Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock"
Annual Meeting financial
"vest upon the earlier of June 2, 2027 or the date on which Calumet, Inc. holds its Annual Meeting in 2027"
A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
SANDERS BRADFORD TIMOTHY

(Last)(First)(Middle)
1060 N CAPITOL AVE
SUITE 6-401

(Street)
INDIANAPOLIS INDIANA 46204

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Calumet, Inc. /DE [ CLMT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)06/02/2026A3,461 (2) (2)Common Stock, par value $0.01 per share3,461$03,461D
Explanation of Responses:
1. Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock, par value $0.01 per share.
2. Restricted Stock Units vest upon the earlier of June 2, 2027 or the date on which Calumet, Inc. holds its Annual Meeting in 2027. Restricted Stock Units will be settled upon vesting.
/s/ Connor J. Egan, as attorney-in-fact06/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CLMT director Bradford Timothy Sanders report?

Bradford Timothy Sanders reported receiving 3,461 Restricted Stock Units in Calumet, Inc. This award is a form of equity compensation and represents future common stock, subject to vesting conditions described in the filing’s footnotes.

How many RSUs were granted to the Calumet (CLMT) director?

The director received 3,461 Restricted Stock Units from Calumet, Inc. Each unit is the economic equivalent of one share of common stock, providing potential future ownership once the units vest and are settled in shares.

When do the newly granted CLMT Restricted Stock Units vest?

The Restricted Stock Units vest on the earlier of June 2, 2027 or the date Calumet, Inc. holds its 2027 Annual Meeting. Vesting must occur before the RSUs are settled into shares of common stock for the director.

What does each Calumet (CLMT) Restricted Stock Unit represent?

Each Restricted Stock Unit is the economic equivalent of one share of Calumet, Inc. common stock. After vesting, the RSUs will be settled in shares, aligning the director’s compensation with shareholder value over time.

Is the CLMT director’s RSU grant a market purchase of stock?

No, the grant is an equity award, not an open-market stock purchase. The director receives 3,461 RSUs at no cash cost, which convert into common shares only after satisfying the vesting conditions set for 2027.